BAC
Bank of America Corporation
BAC has the edge over IBCP overall, supported by stronger valuation and stronger fundamentals.
IBCP
Independent Bank Corporation
IBCP's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
IBCP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
IBCP's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like IBCP.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over IBCP in the historical PE scenario, which offers more potential upside but is not a forecast.
IBCP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $23.36 | -36% |
| Fair | 8.4x | $28.55 | -22% |
| Forward | 9.4x | $36.58 | — |
| Expensive | 11x | $36.35 | -0.6% |
| Current | 11x | $36.58 | — |
Historical ranges are pointers, not guarantees.
IBCP's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over IBCP on the outlook, with more favorable profitability expectations.
IBCP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for IBCP, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over IBCP on earnings, with more consistent year-over-year improvement.
IBCP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.88 | +14% |
| Q3 2026 | $3.40 | +4.3% |
| Q2 2026 | $3.44 | +12% |
| Q1 2026 | $3.35 | +6.7% |
| Q4 2025 | $3.28 | +3.8% |
| Q3 2025 | $3.26 | +11% |
| Q2 2025 | $3.07 | -1.6% |
| Q1 2025 | $3.14 | +6.8% |
| Q4 2024 | $3.16 | +13% |
IBCP earned $3.40 per share over the past year, up 4.3% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over IBCP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
IBCP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.1M | +24% |
| Q2 2026 | $63.2M | +13% |
| Q1 2026 | $58.9M | +8.9% |
| Q4 2025 | $58.3M | -5.9% |
| Q3 2025 | $57.3M | +12% |
| Q2 2025 | $55.9M | -1% |
| Q1 2025 | $54.1M | +2.6% |
| Q4 2024 | $62M | +26% |
IBCP's revenue is growing: $71M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -6.7 points |
| Q2 2026 | 36% | -1.1 points |
| Q1 2026 | 34% | -1 points |
| Q4 2025 | 35% | -1.9 points |
| Q3 2025 | 37% | +3.3 points |
| Q2 2025 | 37% | -4 points |
| Q1 2025 | 35% | -2.2 points |
| Q4 2024 | 37% | +0.3 points |
IBCP has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
IBCP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.1M | +34% |
| Q2 2026 | $16.7M | +0.2% |
| Q1 2026 | -$13.8M | -145% |
| Q4 2025 | $6.4M | -49% |
| Q3 2025 | $16.5M | +5.3% |
| Q2 2025 | $16.7M | +139% |
| Q1 2025 | $30.6M | +52% |
| Q4 2024 | $12.4M | -19% |
IBCP has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over IBCP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
IBCP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.4% | +1.5M shares |
| 1 year | +7.9% | +1.6M shares |
| 3 years | +6.8% | +1.4M shares |
| 5 years | +3.9% | +831K shares |
| Available history | -2.4% | -547K shares |
IBCP has 22M diluted shares, up 7.9% from a year ago, despite $9M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.2M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $4.7M |
| Q3 2025 | $413,000 |
| Q2 2025 | $7.3M |
| Q1 2025 | $33,000 |
| Q4 2024 | — |
IBCP spent $9M buying back its own shares over the past year, up 13% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
IBCP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 0.1x | Very low |
IBCP has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
IBCP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 43.7 | Neutral |
IBCP's weekly RSI is 53 (neutral) and its Stochastic is 44 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IBCP PE vs Financial Services Sector
| Metric | IBCP | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 85 | 63 | 22 pts above |
IBCP has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
IBCP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1% above |
| 20 week MA | $36.7 | 0.4% below |
| 50 week MA | $35.3 | 3.8% above |
| 100 week MA | $33.7 | 8.5% above |
| 200 week MA | $29.1 | 26% above |
IBCP has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
IBCP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.6 | $18.6 | -18% |
| 2021 | $18.6 | $23.3 | +25% |
| 2022 | $23.3 | $24.2 | +4% |
| 2023 | $24.2 | $26.0 | +7.4% |
| 2024 | $26.0 | $34.7 | +33% |
| 2025 | $34.7 | $33.1 | -4.5% |
| 2026 YTD | $33.1 | $36.6 | +10% |
IBCP has the edge over BAC on returns for 2026, with the stronger performance.